The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Vanda Pharmaceuticals Inc

Nasdaq: VNDA
Last

(U.S.) $16.00

Today's change0.00 0.00%
Updated December 6 4:00 PM -5GMT. Delayed by at least 15 minutes.
 

Vanda Pharmaceuticals Inc

Nasdaq: VNDA
Last

(U.S.) $16.00

Today's change0.00 0.00%
Updated December 6 4:00 PM -5GMT. Delayed by at least 15 minutes.

Vanda Pharmaceuticals Inc closed at (U.S.)$16.00.

Shares have lost 4.76% over the last five days, but have gained 71.86% over the last year to date. This security has outperformed the S&P 500 by 72.81% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $16.00
  • High--
  • Low--
  • Bid / Ask(U.S.) $15.15 / (U.S.) $17.80
  • YTD % change+71.86%
  • Volume0
  • Average volume (10-day)558,466
  • Average volume (1-month)613,757
  • Average volume (3-month)780,985
  • 52-week range(U.S.) $6.91 to (U.S.) $18.00
  • Beta1.41
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.75
Updated December 6 4:00 PM -5GMT. Delayed by at least 15 minutes.

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue38363332
Total other revenue--------
Total revenue38363332
Gross profit31302726
Total cost of revenue7666
Total operating expense39414647
Selling / general / administrative22252929
Research & development7789
Depreciation / amortization3333
Interest expense (income), net operating--------
Unusual expense (income)------0
Other operating expenses, total--------
Operating income-1-5-12-15
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax0-5-12-15
Income after tax0-5-12-15
Income tax, total--------
Net income0-5-12-15
Total adjustments to net income--------
Net income before extra. items0-5-12-15
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items0-5-12-15
Inc. avail. to common incl. extra. items0-5-12-15
Diluted net income0-5-12-15
Dilution adjustment--------
Diluted weighted average shares44434343
Diluted EPS excluding extraordinary itemsvalue per share-0.01-0.11-0.29-0.35
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.01-0.11-0.29-0.35